These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21999772)

  • 1. Modelling the impact of antiretroviral therapy on the epidemic of HIV.
    Williams BG; Lima V; Gouws E
    Curr HIV Res; 2011 Sep; 9(6):367-82. PubMed ID: 21999772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
    Wood E; Braitstein P; Montaner JS; Schechter MT; Tyndall MW; O'Shaughnessy MV; Hogg RS
    Lancet; 2000 Jun; 355(9221):2095-100. PubMed ID: 10902622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
    Jewell BL; Mudimu E; Stover J; Ten Brink D; Phillips AN; Smith JA; Martin-Hughes R; Teng Y; Glaubius R; Mahiane SG; Bansi-Matharu L; Taramusi I; Chagoma N; Morrison M; Doherty M; Marsh K; Bershteyn A; Hallett TB; Kelly SL;
    Lancet HIV; 2020 Sep; 7(9):e629-e640. PubMed ID: 32771089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus.
    Blocker ME; Cohen MS
    Infect Dis Clin North Am; 2000 Dec; 14(4):983-99. PubMed ID: 11144648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral treatment for the prevention of HIV transmission.
    Granich R; Crowley S; Vitoria M; Lo YR; Souteyrand Y; Dye C; Gilks C; Guerma T; De Cock KM; Williams B
    J Int AIDS Soc; 2010 Jan; 13():1. PubMed ID: 20205768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral-based HIV prevention strategies for women.
    Chirenje ZM; Marrazzo J; Parikh UM
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1177-86. PubMed ID: 20954882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The History of the HIV/AIDS Epidemic in Africa.
    Kagaayi J; Serwadda D
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):187-93. PubMed ID: 27188298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa.
    Mutevedzi PC; Newell ML
    Trop Med Int Health; 2014 Sep; 19(9):1015-28. PubMed ID: 24976370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The HIV pandemic in the year 2007, an overview].
    Bartelsman M; Veeken H
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2655-60. PubMed ID: 18179081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV.
    Ghosn J; Taiwo B; Seedat S; Autran B; Katlama C
    Lancet; 2018 Aug; 392(10148):685-697. PubMed ID: 30049419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antiretroviral drugs to prevent sexual transmission of HIV.
    Cohen MS; Hosseinipour M; Kashuba A; Butera S
    Curr Clin Top Infect Dis; 2002; 22():214-51. PubMed ID: 12520656
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
    Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
    J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the impact of HIV prevention and treatment for men who have sex with men on HIV epidemic trajectories in low- and middle-income countries.
    Wirtz AL; Walker DG; Bollinger L; Sifakis F; Baral S; Johns B; Oelrichs R; Beyrer C
    Int J STD AIDS; 2013 Jan; 24(1):18-30. PubMed ID: 23512511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review.
    Muhula S; Gachohi J; Kombe Y; Karanja S
    PLoS One; 2022; 17(2):e0263663. PubMed ID: 35139118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention.
    Hunter DJ
    Epidemiology; 1993 Jan; 4(1):63-72. PubMed ID: 8420583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines.
    Phillips AN; Bansi-Matharu L; Venter F; Havlir D; Pozniak A; Kuritzkes DR; Wensing A; Lundgren JD; Pillay D; Mellors J; Cambiano V; Jahn A; Apollo T; Mugurungi O; Ripin D; Da Silva J; Raizes E; Ford N; Siberry GK; Gupta RK; Barnabas R; Revill P; Cohn J; Calmy A; Bertagnolio S
    Lancet HIV; 2020 Mar; 7(3):e193-e200. PubMed ID: 32035041
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.